Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2 Amino 6 Propylaminotetrahydrobenzothiazole
2. 2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole
3. 2-amino-6-propylaminotetrahydrobenzothiazole
4. 4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazole-diamine
5. 6,7-tetrahydro-n6-propyl-2,6-benzothiazolediamine Dihydrochloride Monohydrate
6. Kns 760704
7. Kns-760704
8. Kns760704
9. Mirapex
10. Pramipexol
11. Pramipexol Dihydrobromide, (+-)-isomer
12. Pramipexol Dihydrochloride, (s)-isomer
13. Pramipexol, (+-)-isomer
14. Pramipexol, (r)-isomer
15. Pramipexole
16. Pramipexole Dihydrochloride
17. Pramipexole Dihydrochloride Anhydrous
18. Pramipexole Hydrochloride Monohydrate
19. Sifrol
20. Snd 919
21. Snd 919cl2x
22. Snd-919
23. Snd-919cl2x
24. Snd919cl2x
1. 104632-28-2
2. (r)-pramipexole
3. (r)-n6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine
4. R-(+)-pramipexole
5. (6r)-6-n-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
6. Wi638gus96
7. Kns-760704
8. (r)-pramipexole Dihydrochloride
9. Dexpramipexole Dihydrochloride
10. Dexpramipexole [usan:inn]
11. Unii-wi638gus96
12. Dexpramipexole (usan/inn)
13. Dexpramipexole [inn]
14. Schembl74780
15. Dexpramipexole [usan]
16. Mls006011813
17. Chembl249420
18. Dexpramipexole [who-dd]
19. Dtxsid50146624
20. Bcp12512
21. Zinc3831352
22. 2,6-benzothiazolediamine, 4,5,6,7-tetrahydro-n6-propyl-, (6r)-
23. Bdbm50568780
24. Hy-17355b
25. Stk621530
26. Akos005555111
27. Cs-1196
28. Db15130
29. Ac-36724
30. As-56557
31. Smr004703492
32. D09886
33. F19514
34. Q5268345
35. (6r)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazole-diamine
36. (6r)-n6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
37. (6r)-n~6~-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
38. (r)-4,5,6,7-tetrahydro-6-(propylamino)-benzothiazole-2-amine
39. 2,6-benzothiazolediamine, 4,5,6,7-tetrahydro-n6-propyl-, (r)-
| Molecular Weight | 211.33 g/mol |
|---|---|
| Molecular Formula | C10H17N3S |
| XLogP3 | 1.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 211.11431873 g/mol |
| Monoisotopic Mass | 211.11431873 g/mol |
| Topological Polar Surface Area | 79.2 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 188 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
Antiparkinson Agents
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)
Dopamine Agonists
Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Dexpramipexole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dexpramipexole, including repackagers and relabelers. The FDA regulates Dexpramipexole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dexpramipexole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Dexpramipexole supplier is an individual or a company that provides Dexpramipexole active pharmaceutical ingredient (API) or Dexpramipexole finished formulations upon request. The Dexpramipexole suppliers may include Dexpramipexole API manufacturers, exporters, distributors and traders.
Dexpramipexole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dexpramipexole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dexpramipexole GMP manufacturer or Dexpramipexole GMP API supplier for your needs.
A Dexpramipexole CoA (Certificate of Analysis) is a formal document that attests to Dexpramipexole's compliance with Dexpramipexole specifications and serves as a tool for batch-level quality control.
Dexpramipexole CoA mostly includes findings from lab analyses of a specific batch. For each Dexpramipexole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dexpramipexole may be tested according to a variety of international standards, such as European Pharmacopoeia (Dexpramipexole EP), Dexpramipexole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dexpramipexole USP).
LOOKING FOR A SUPPLIER?
